Sherman Oaks, California Clinical Trials

A listing of Sherman Oaks, California clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1510 clinical trials
featured
Memory Research Study

This study is looking for people aged 60-90 who have mild cognitive impairment. The study is also looking for people with normal cognition, as a comparison. The study is testing a medical device to determine whether brain stimulation improves memory.

Jane & Terry Semel Institute for Neuroscience and Human Behavior
 (5.4 away) Contact site
  • 15 views
  • 15 Sep, 2020
  • 1 location
featured
[ONLINE] Alzheimer's Disease Center Research Registry

This study is looking for people over the age of 55 who have normal cognition, memory problems, or mild dementia. The study is also looking for people who are care partners of someone who has dementia. The study is intended to match people with studies that may be a good …

mild dementia
Online238
 (6.4 away) Contact site
  • 124 views
  • 28 Jan, 2021
  • +252 other locations
featured
[ONLINE] Understanding Psychological Distress and Sleep Quality in Former Dementia Caregivers

This study is looking for adults who were caregivers for a person with Alzheimer’s before their death. Contact Person Kristin Corey Postdoctoral Research Fellow 508 813-0374coreykl@upenn.edu

Online238
 (6.4 away) Contact site
  • 303 views
  • 01 Oct, 2020
  • +252 other locations
featured
[Remote] Genomic Discoveries in African-Americans.

This study is looking for African-American families that have been affected by Alzheimer’s. The study wants to learn about the genetic causes of Alzheimer’s.

dementia
[Remote] Genomic Discoveries in African-Americans.
 (6.4 away) Contact site
  • 0 views
  • 26 May, 2021
  • +243 other locations
featured
[Online] Understanding Eating and Health

The online study involves two parts: 1) taking an online survey with questions about yourself, your health, and your eating habits and preferences; 2) entering what you've eaten on 3 separate days using an online 24-hour recall website hosted by the NIH (called the ASA24).https://redcap.emich.edu/redcap/surveys/?s=XDAFEJ9NXF

[Online] Understanding Eating and Health
 (6.4 away) Contact site
  • 0 views
  • 29 Apr, 2021
  • +238 other locations
featured
A safety and Tolerability Study of INCB053915 in Combination With INCB050465 in Diffuse Large B-Cell Lymphoma

The purpose of this study is to evaluate the safety and tolerability of INCB053914 in combination with INCB050465 in relapsed or refractory Diffuse Large B-Cell Lymphoma (DLBCL).  

lymphoma
lymphomas
b-cell lymphoma
UCLA HEALTHCARE HEMATOLOGY-ONCOLOGY
 (8.5 away) Contact site
  • 45 views
  • 14 Dec, 2020
  • +4 other locations
featured
A Phase 1 Open-Label, Dose-Escalation, Safety and Tolerability Study of INCAGN02385 in Participants With Select Advanced Malignancies

The purpose of this study is to determine the safety, tolerability, and preliminary efficacy of INCAGN02385 in participants with advanced malignancies.  This investigational intervention treatment uses a single biological drug and is conducted in two parts. Part 1: INCAGN02385 at the protocol-defined starting dose administered every 2 weeks (Q2W), with dose …

metastatic cervical cancer
carcinoma
urothelial carcinoma
ovarian cancer
The Angeles Clinic and Research Institute
 (7.2 away) Contact site
  • 156 views
  • 23 Nov, 2020
  • +3 other locations
featured
A Phase 1, Open-Label, Dose-Escalation, Safety and Tolerability Study of INCAGN02390 in Participants With Select Advanced Malignancies

The purpose of this study is to determine the safety, tolerability, and preliminary efficacy of INCAGN02390 in participants with advanced malignancies. This investigational intervention treatment uses a single biological drug and is conducted in two parts. Part 1: INCAGN02390 at the protocol-defined starting dose administered every 2 weeks (Q2W), with …

advanced cancer
cancer
The Angeles Clinic and Research Institute
 (7.2 away) Contact site
  • 128 views
  • 14 Dec, 2020
  • +3 other locations
featured
VIVID-1, a clinical research study for adults 18–80 with moderately to severely active Crohn’s disease.

A phase 3 research study of an injectable investigational medicine for adults ages 18 to 80 with moderate to severe Crohn’s disease. Note that study participants may receive the investigational medication, a currently approved Crohn’s medication, or placebo. The study comprises four periods: screening, treatment period 1, treatment period 2, …

inflammatory bowel disease
crohn's disease
gastrointestinal diseases
gastrointestinal disorder
VIVID-1 Study Center
 (6.7 away) Contact site
  • 66 views
  • 20 Jul, 2021
  • +73 other locations
featured
Have you had a slow progression of memory decline in the last year or so?

Have you had a slow progression of memory decline in the last year or so?

Schuster Medical Research Institute
 (0.5 away) Contact site
  • 388 views
  • 08 Dec, 2020
  • 1 location